Morgan Stanley’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $32 | Buy |
|
|||||
|
2023
Q3 | $32 | Buy |
|
|||||
|
2023
Q2 | $73 | Sell |
|
|||||
|
2023
Q1 | $363 | Sell |
|
|||||
|
2022
Q4 | $2.16K | Sell |
|
|||||
|
2022
Q3 | $21K | Sell |
|
|||||
|
2022
Q2 | $111K | Buy |
|
|||||
|
2022
Q1 | $19K | Buy |
|
|||||
|
2021
Q4 | $19K | Sell |
|
|||||
|
2021
Q3 | $36K | Buy |
|
|||||
|
2021
Q2 | $29K | Hold |
|
|||||
|
2021
Q1 | $34K | Buy |
|
|||||
|
2020
Q3 | – | Hold |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $2K | Sell |
|
|||||
|
2019
Q4 | $4K | Sell |
|
|||||
|
2019
Q3 | $8K | Hold |
|
|||||
|
2019
Q2 | $14K | Hold |
|
|||||
|
2019
Q1 | $23K | Hold |
|
|||||
|
2018
Q4 | $10K | Sell |
|
|||||
|
2018
Q3 | $28K | Sell |
|
|||||
|
2018
Q2 | $17K | Hold |
|
|||||
|
2018
Q1 | $31K | Hold |
|
|||||
|
2017
Q4 | $34K | Sell |
|
|||||
|
2017
Q3 | $51K | Hold |
|
|||||
|
2017
Q2 | $86K | Hold |
|
|||||
|
2017
Q1 | $120K | Hold |
|
|||||
|
2016
Q4 | $125K | Hold |
|
|||||
|
2016
Q3 | $161K | Hold |
|
|||||
|
2016
Q2 | $108K | Sell |
|
|||||
|
2016
Q1 | $123K | Hold |
|
|||||
|
2015
Q4 | $80K | Hold |
|
|||||
|
2015
Q3 | $89K | Hold |
|
|||||
|
2015
Q2 | $179K | Sell |
|
|||||
|
2015
Q1 | $288K | Hold |
|
|||||
|
2014
Q4 | $359K | Buy |
|
|||||
|
2014
Q3 | $263K | Sell |
|
|||||
|
2014
Q2 | $360K | Buy |
|
|||||
|
2014
Q1 | $306K | Buy |
|
|||||
|
2013
Q4 | $319K | Buy |
|
|||||
|
2013
Q3 | $199K | Sell |
|
|||||
|
2013
Q2 | $437K | Buy |
|